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Background and aims: Infectious diseases contribute to stroke risk, and are associated with socioeco-
nomic status (SES). We tested the hypotheses that the aggregate burden of infections increases the risk of
ischemic stroke (IS) and partly explains the association between low SES and ischemic stroke.
Methods: In a caseecontrol study with 470 ischemic stroke patients and 809 age- and sex-matched
controls, randomly selected from the population, antibodies against the periodontal microbial agents
Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis, against Chlamydia pneumonia,
Mycoplasma pneumoniae (IgA and IgG), and CagA-positive Helicobacter pylori (IgG) were assessed.
Results: IgA seropositivity to two microbial agents was signiﬁcantly associated with IS after adjustment
for SES (OR 1.45 95% CI 1.01e2.08), but not in the fully adjusted model (OR 1.32 95% CI 0.86e2.02). By
trend, cumulative IgA seropositivity was associated with stroke due to large vessel disease (LVD) after full
adjustment (OR 1.88, 95% CI 0.96e3.69). Disadvantageous childhood SES was associated with higher
cumulative seropositivity in univariable analyses, however, its strong impact on stroke risk was not
inﬂuenced by seroepidemiological data in the multivariable model. The strong association between
adulthood SES and stroke was rendered nonsigniﬁcant when factors of dental care were adjusted for.
Conclusions: Infectious burden assessed with ﬁve microbial agents did not independently contribute to
ischemic stroke consistently, but may contribute to stroke due to LVD. High infectious burden may not
explain the association between childhood SES and stroke risk. Lifestyle factors that include dental
negligence may contribute to the association between disadvantageous adulthood SES and stroke.
© 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Stroke, especially ischemic stroke (IS), is a multifactorial disease
with numerous contributing risk factors. These risk factors are
target of preventive strategies attempting to mitigate the future
burden of stroke. Current risk factor models may explain about 90%
of ischemic stroke occurrence [1]. However, some epidemiological, St€adtisches Klinikum Lud-
., Germany.
rved.aspects of stroke may not be sufﬁciently explained yet [2e4].
Infectious and inﬂammatory diseases, as well as unfavorable
socioeconomic conditions have been described as contributors to
the risk of stroke [4e7]. Different chronic infections have been
found to be associated with stroke, including clinical periodontitis,
infections with the periodontal pathogens Porphyromonas gingivalis
(Pg) and Aggregatibacter actinomycetemcomitans (Aa), infections
with Helicobacter pylori (Hp), and particularly with Hp strains car-
rying the cytotoxin-associated gene A (CagA) [8e11]. Chlamydia
pneumonia (Cp), Mycoplasma pneumonia (Mp), and Legionella
pneumophila (Lp) are as well among those microbial agents whose
link with stroke has been discussed [12]. However, the results of
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hypothesis suggests that the aggregate burden of microbial agents
to which an individual has been exposed to during his or her whole
lifetime, rather than single pathogens, increases the risk of stroke
(“infectious burden concept”) [5]. In a recent analysis of the
Northern Manhattan Study, no association was found between the
risk of stroke and any of the ﬁve serologies to common infections
(Cp, Hp, Cytomegalovirus, Herpes Simplex Virus 1 and 2). However,
a derived infectious burden index showed an association with
stroke [14].
Socioeconomic status (SES) is negatively associatedwith the risk
of stroke [15]. In a case-control study, we recently showed that SES
during childhood and adulthood are each independently linked to
stroke risk [16]. Several chronic infectious diseases such as peri-
odontitis and infection with Hp are more common in people with
disadvantageous social conditions [17]. Thus, it seems likely that
chronic infections contribute to the association between socio-
economic conditions and stroke, togetherwith other factors such as
a health neglecting lifestyle.
Based on the data from the same case-control study, we tested
the hypotheses that the infectious burden (¼aggregate number of
seropositivities to selected infectious agents) is associated with the
risk of IS and that chronic infections and elements of a health
neglecting lifestyle contribute to the association between SES
during childhood, adolescence, and adulthood and the risk of IS.
2. Patients and methods
The “GENESIS” study is a case-control study with 470 ﬁrst-ever
ischemic stroke (FEIS) cases (40% women, mean age 66.5 ± 10.8
years; 60% men, 65.5 ± 10.7) and 809 age- and sex-matched con-
trols (41.8% women, 66.4 ± 11.1; 58.2% men, 67.9 ± 9.5), randomly
selected from the general population. The target population con-
sists of individuals aged 18e80 years, living in the city of Ludwig-
shafen am Rhein in South-West Germany. „GENESIS“ was
established within the framework of the Ludwigshafen Stroke
Study (LuSST), a population-based stroke registry that started on
January 1st, 2006, using standard deﬁnitions and multiple over-
lappingmethods of case-ascertainment in order to identify all cases
with incident stroke or transient ischemic attack among the pop-
ulation of Ludwigshafen (163.340 inhabitants on December 31,
2009). A detailed description of LuSSt and the „GENESIS“ study
have been published recently [16,18]. The study was approved by
the ethics committee of the Landes€arztekammer Rheinland-Pfalz
(837.333.05(4991)).
2.1. Inclusion and exclusion criteria
Inclusion criteria besides age and permanent residency in the
study area were Caucasian ethnicity and written informed consent
to study participation. Inclusion criterion for cases was the diag-
nosis of a FEIS based on an acute neurological deﬁcit lasting >24 h
with no other reason than cerebral ischemia. All cases received a
cerebral CT or MRI. Exclusion criteria for both cases and controls
included any previous stroke, myocardial infarctionwithin 90 days,
dementia, severe aphasia, insufﬁcient understanding of the
German language or any other relevant communication barrier and
severe disability that precludes interview participation.
2.2. Recruitment
For recruitment of controls, a random sample of Ludwigshafen
residents was drawn from the population registry including name,
age, sex and address. Subsamples were consecutively taken to
match the age and sex distribution of cases. Those selected receivedinvitation letters with detailed information on the study and
request for their participation. The participation rate for controls
was 46.6%. The cases included incident stroke cases from the LuSSt
registry. According to the study protocol only in-patients at the
Klinikum Ludwigshafen were asked for participation in “GENESIS”,
since only few patients in the area did not attend this hospital. This
group represents about 89% of all cases in LuSSt. The participation
rate for cases was 73.7%.
2.3. Data collection and laboratory tests
Cases and controls were interviewed by trained interviewers
using a standardized questionnaire. We collected data on age, sex,
anthropometric measures, previous diseases, and previous visits to
a dentist as markers of health behavior, number of teeth, smoking,
alcohol intake, physical activity, dietary patterns, medication and
social history. In both, cases and controls, blood pressure was
measured after 5 min of resting, a 12-lead electrocardiogram and a
Duplex-sonography of brain supplying arteries were performed.
Venous blood samples were taken in cases and controls.
Serum was separated by low-speed centrifugation and stored
at 70 C until analysis. Serum levels of IgA and IgG antibodies
against Aa and Pg were determined by multi-serotype-ELISA as
previously described [19]. Serum levels of IgG antibodies againstHp
and of IgG and IgA antibodies against Cp and Mp were assessed by
using commercial enzyme immunoassays (Enzygnost® and
Novagnost® Siemens Healthcare) at the Institute of Clinical
Chemistry, Klinikum Ludwigshafen.
2.4. Deﬁnition of variables
Cardiovascular risk factors were deﬁned according to current
national and international guidelines and have been described in
detail [20]. A detailed presentation of the SES measures has been
published recently [16]. Etiological subtypes of IS were ascertained
using modiﬁed TOAST criteria (Trial of ORG 10172 in Acute Stroke
Treatment) as previously described [20]. The category “large vessel
disease” (LVD) included “probable atherothrombotic stroke” (AT)
and stroke due to “large artery atherosclerosis” (LAA). In 159 cases,
etiology of IS was classiﬁed as LVD (19.7% of all cases).
2.5. Statistical analysis
We report absolute and relative frequencies of risk factors, SES
and seropositivities to infectious agents by caseecontrol status.
Infectious burden was calculated as cumulative IgA-positivity,
cumulative IgG-positivity, and aggregated IgG/IgA-positivity.
Odds ratio (OR) estimates and 95% conﬁdence intervals (CI) are
presented based on conditional logistic regression models,
conditioned on age (2-year-age groups) and sex, and adjusted for
risk factors, SES, and the respective other infection indicators.
Associations between the number of seropositivities to infectious
agents and SES in childhood, adolescence, and adulthood were
investigated by the Jonckheere-Terpstra trend test. To control for a
potential bias owing to a lower response of controls from more
disadvantaged social background, we performed a sensitivity
analysis, comparing school education data in our control group
with those of the general population received from the municipal
statistical ofﬁce. Although individuals with low school education
were moderately underrepresented in our control group, results
regarding socioeconomic factors as stroke risk factor were altered
only to a minor degree by adjustment for a differential response
rate in controls [16]. For all analyses, the statistical software R was
used, conditional logistic regression estimates were obtained
through the R package survival, the Jonckheere-Terpstra trend test
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Distribution of traditional risk factors, lifestyle risk factors, so-
cioeconomic risk score and dental risk factors in cases and controls
is shown as a supplementary table as previously published [16].
FEIS cases showed higher rates of seropositivity regarding IgA an-
tibodies against Aa and IgG antibodies against CagA-positive strains
of Hp but lower rate of seropositivity to IgG antibodies against Mp
in analyses adjusted for age and sex only. Cumulative IgA-
seropositivity against 2 bacterial strains was associated with
higher stroke risk, but cumulative IgG or combined IgA/IgG sero-
positivity was not (Table 1).
Adjustment for SES in childhood, adolescence and adulthood
and further adjustment for cardiovascular risk factors and dental
parameters had mostly small effects on the risk estimates of the
immunological variables (Fig. 1A). The association between Hp and
IS was weakened and rendered nonsigniﬁcant by adjustment for
SES. IgA seropositivity to two microbial agents was signiﬁcantly
associated with IS after adjustment for SES (OR 1.45 95% CI
1.01e2.08). Fully adjustment rendered effect of IgA-seropositivity
to two microbial agents on stroke risk nonsigniﬁcant (OR 1.32
95% CI 0.86e2.02).
Distribution of risk factors and data on SES was reported pre-
viously [16]. Data on dental health showed that patients suffered
more often from advanced tooth loss (8e14 teeth remaining) and
used dental health care service less than controls (Table 2).
When analyzing cases with LVD separately, IgA-seropositivity
for Aa (OR 1.68; 95% CI 1.15e2.46) and Cp (OR 1.89; 95% CI
1.14e3.13), cumulative IgA-seropositivity for 2 (OR 2.14; 95% CITable 1
Distribution, odds ratios and 95%-conﬁdence intervals of serological testing and
aggregate number of seropositivities to infectious agents for all ischemic stroke
cases.
Controls % Cases % Crude ORa 95% CI
Mycoplasma pneumonia
IgA 24 2.98 15 3.22 1.04 0.53e2.06
IgG 445 55.28 232 49.79 0.74 0.59e0.95
Porphyromonas gingivalis
IgA 434 53.91 253 54.88 1.06 0.83e1.35
IgG 594 73.79 344 74.62 1.08 0.81e1.42
A. actinomycemtemcomitans
IgA 220 27.33 146 31.67 1.33 1.02e1.73
IgG 244 30.31 118 25.60 0.86 0.66e1.13
Chlamydia pneumonia
IgA 73 9.07 53 11.37 1.28 0.86e1.90
IgG 235 29.19 145 31.12 1.08 0.83e1.40
Helicobacter pylori
IgG 243 30.19 182 39.06 1.39 1.08e1.78
Cumulative IgA positivity
0 264 32.88 142 30.80 1.00
1 364 45.33 189 41.00 1.00 0.75e1.33
2 142 17.68 112 24.30 1.47 1.05e2.08
3e4 33 4.11 18 3.90 1.25 0.66e2.36
Cumulative IgG positivity
0e1 220 27.40 125 27.11 1.00
2 271 33.75 160 34.71 1.09 0.80e1.48
3 227 28.27 109 23.64 0.86 0.62e1.20
4e5 85 10.59 67 14.53 1.29 0.85e1.95
Cumulative overall positivity
0e1 184 22.91 103 22.34 1.00
2 264 32.88 148 32.10 1.03 0.74e1.43
3 235 29.27 120 26.03 0.94 0.67e1.33
4e5 120 14.94 90 19.52 1.29 0.88e1.90
Few data missing: in controls: Mp, Pg, Aa, Cp, Hp: n ¼ 4; in cases: Mp, Cp: 4; Pg,
Aa:n ¼ 9.
a Conditioned on age (2-year-groups) and sex.1.28e3.56) and 3e4 microbial agents (OR 2.50; 95% CI 1.11e5.65),
and IgG-seropositivity for Hp (OR 1.63; 95% CI 1.14e2.34) were
associated with stroke in age- and sex-adjusted analyses (Fig. 1B;
Table 3). Adjustment for SES and further adjustment for cardio-
vascular risk factors only marginally changed the effect estimates
for most seroepidemiological analyses including IgA against Aa. The
association for Cp IgA and Hp IgG was weakened and rendered
nonsigniﬁcant as was the cumulative IgA-seropositivity (two
agents: OR 1.88, 95% CI 0.96e3.69; 3e4 agents: OR 1.58 95% CI
0.51e4.89). Cp-IgG-seropositivity was associatedwith higher risk of
stroke due to small vessel disease SVD (OR 1.53; 95% CI 1.04e2.25),
an effect that was not found after further adjustment (OR 1.12; 95%
CI 0.67e1.86).
In unadjusted analyses, poor SES in childhood was associated
with higher numbers of seropositivities to infectious agents in
controls (p ¼ 0.02; Jonckhere-test), but particularly in cases
(p ¼ 0.0001) (Fig. 2). This association was detected for SES in
adolescence for cases as well (p ¼ 0.03), but not for controls
(p ¼ 0.2) and did not exist in either group regarding adulthood
(cases: p ¼ 0.1; controls: p ¼ 0.6).
Adjusting for infectious burden had no notable inﬂuence on the
association between of the risk of stroke and SES in childhood,
adolescence, or adulthood (Table 2, model 2). The link between SES
in adulthood and stroke risk was reduced and rendered nonsig-
niﬁcant when dental status and frequency of dental health care
were additionally adjusted for (Table 2, model 3).
4. Discussion
Using a large age- and sex-matched case-control study
including detailed data on SES, we found that Aa-IgA antibody
levels were positively, and Mp-IgG antibody levels were negatively
associated with FEIS independent of conventional risk factors and
SES. The increased risk found for Aa was mainly due to an associ-
ation with stroke due to LVD, whose main contributor is athero-
sclerosis, whereas the inverse association found for Mp was not
signiﬁcantly linked to any stroke subtype. The other threemicrobial
agents studied (Cp, Hp and Pg) were not independently associated
with the overall stroke risk. Cumulative IgA seropositivity was
associated with higher risk of FEIS in univariable analysis and after
adjustment for SES, but not in the fully adjusted model.
Several serological studies have suggested single chronic in-
fections, as well as the burden composed of several chronic in-
fections as risk factors for stroke [24,25]. The research has mainly
focused on H. pylori, Cytomegalovirus, Herpes simplex virus, peri-
odontal pathogens, or their combinations [9,10,12,14,26e29]. We
investigated the ﬁve selected microbes for the following reasons:
there is ample evidence that periodontitis increases the risk of
stroke and Aa and Pg are among the most relevant periodontal
agents [30]. We had previously shown that in our region CagA
positive Hp strains are linked to stroke risk albeit results e.g. from
Asia are at variance [11,31]. In addition, we selected Cp and Mp
among respiratory agents as particularly Cp previously was in the
focus of research.
Pg and Aa have different characteristics and virulence proﬁles,
but they are both considered to be etiologically linked to peri-
odontitis, which is the sixth most common medical condition ac-
cording to the Global Burden of Disease Study [32]. Pg is very
frequent in chronic adult periodontitis, whereas Aa is recurrently
encountered in a more aggressive form of the disease, often already
starting in adolescence. Both pathogens, however, are very com-
mon in adults: according to a Finnish population-based study Pg
and Aa are found in 35.5% and 20.0% of saliva samples, respectively
[33]. In the present study, only Aa was associated with increased
stroke risk, which is in agreement with an earlier prospective study
Fig. 1. Odds ratios and 95%-conﬁdence intervals of ischemic stroke by serology of chronic infections in three different models: (1) conditioned on age and sex, (2) addi-
tionally adjusted for socioeconomic risk scores in childhood, adolescence and adulthood, and (3) additionally for all common known risk factors (hypertension, diabetes
mellitus, hypercholesterolemia, atrial ﬁbrillation, smoking, (high) alcohol consumption, physical activity, fruit or vegetable consumption, meat consumption, number of
teeth, number of dentist visit). (A) Ischemic stroke overall, (B) ischemic stroke due to large vessel disease.
Table 2
Odds ratios and 95%-conﬁdence intervals in three multivariable models, for all
ischemic stroke cases.
Model 1 Model 2 Model 3
OR 95% CI OR 95% CI OR 95% CI
Risk score childhood
Low 1 1 1
Middle 1.47 1.04e2.09 1.42 1.0e2.02 1.46 1.02e2.09
High 1.77 1.20e2.60 1.72 1.16e2.55 1.68 1.11e2.52
Risk score adolescence
Low 1 1 1
Middle 1.28 0.90e1.82 1.26 0.89e1.80 1.31 0.91e1.88
High 1.64 0.97e2.78 1.64 0.96e2.79 1.62 0.93e2.82
Risk score adulthood
Low
Middle 0.89 0.62e1.29 0.90 0.62e1.31 0.82 0.56e1.20
High 1.74 1.16e2.60 1.73 1.15e2.59 1.47 0.97e2.23
Cumulative IgA positivity
0 1 1
1 1.00 0.72e1.40 1.03 0.73e1.45
2 1.30 0.86e1.96 1.32 0.86e2.02
3e4 0.89 0.41e1.94 0.77 0.33e1.78
Cumulative IgG positivity
0e1 1 1
2 1.02 0.71e1.47 1.09 0.75e1.59
3 0.87 0.59e1.30 0.92 0.61e1.38







>1 per year 1
1 per year 0.94 0.69e1.29
<1 per year 1.32 0.79e2.19
Never 4.47 2.41e8.28
In addition to the depicted parameters all models include age (2-year-groups) sex,
hypertension, diabetes mellitus, hypercholesterolemia, atrial ﬁbrillation, coronary
heart disease, chronic heart failure, peripheral arterial disease, current smoking,
high alcohol consumption, physical activity, fruit/vegetable consumption, meat
consumption as published in Ref. [16].
Table 3
Distribution, odds ratios and 95%-conﬁdence intervals of serological testing and aggrega
LVD % Crude ORa 95% CI CE %
Mycoplasma pneumonia
IgA 6 3.75 1.13 0.43e2.94 6 5.61
IgG 83 51.88 0.76 0.53e1.09 48 44.86
Porphyromonas gingivalis
IgA 97 60.62 1.28 0.89e1.85 59 55.14
IgG 126 78.75 1.29 0.83e2.00 73 68.22
Aggregatibacter actinomycem
IgA 59 36.88 1.68 1.15e2.46 34 31.78
IgG 41 25.62 0.86 0.58e1.29 30 28.04
Chlamydia pneumonia
IgA 26 16.25 1.89 1.14e3.13 8 7.48
IgG 52 32.5 1.09 0.74e1.60 26 24.3
Helicobacter pylorii
IgG 71 44.38 1.63 1.14e2.34 41 38.32
Cumulative IgA positivity
0 38 23.75 1 29 27.10
1 64 40 1.31 0.83e2.07 43 40.19
2 47 29.38 2.14 1.28e3.56 29 27.10
3e4 10 6.25 2.5 1.11e5.65 2 1.87
Cumulative IgG positivity
0-1 35 21.88 1 33 30.84
2 57 35.62 1.23 0.77e1.98 33 30.84
3 39 24.38 0.98 0.59e1.64 22 20.56
4e5 28 17.5 1.66 0.91e3.01 15 14.02
Cumulative overall positivity
0-1 28 17.5 1 26 24.3
2 48 30 1.08 0.64e1.81 36 33.64
3 42 26.25 1.08 0.63e1.85 24 22.43
4e5 41 25.62 1.83 1.04e3.22 17 15.89
a Conditioned on age (2-year-groups) and sex.
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izing antibodies have been associated with decreased risk of stroke
further supporting a relevant role of this microbe and its virulence
factors in cerebrovascular diseases [34]. Seropositivity to Aa does
not necessarily denote current periodontitis, but it reﬂects pres-
ence of the pathogen in oral bioﬁlm and the antibody levels are
strongly correlated with oral bacterial load [35]. In periodontitis,
serum IgA-class antibodies to the pathogen are considered to
reﬂect repeated exposure, which occurs during daily dental rou-
tines through bleeding and infected gums. Recurrent bacteraemia,
endotoxemia, and spread of antigens lead to low-grade systemic
inﬂammation regardless of the bacterial source [36].
Mp-seropositivity was found to be associated with the risk of
stroke and coronary events in several studies, whereas other
studies' results were negative [37,38]. Our study is the ﬁrst one
showing a negative association, which however might be a
spurious result.
Our study did not conﬁrm the hypothesis of signiﬁcant associ-
ations between infectious burden measured with cumulative IgA-
serology, IgG-serology, or aggregated IgG/IgA-positivity to ﬁve
chronic pathogens, and the overall risk of IS. Heterogeneity of IS
etiology might partly explain the study results. Atherosclerosis is
thought to play a key role in mechanisms linking chronic infections
and IS [14,39]. In stroke etiology, atherosclerosis is the main
contributor to stroke of LVD origin. Our study showed an associa-
tion between cumulative IgA-seropositivity and IS in the LVD
subgroup, however, this association was weakened after adjust-
ment for all covariates.
We found that disadvantageous childhood socioeconomic con-
ditions reﬂect increased risk of stroke independent of SES in later
life stages and independent of conventional risk factors, including
smoking, alcohol consumption, diet and physical activity [16]. The
etiology of this association is hardly understood. We had hypoth-
esized that high infectious burden may partly explain this corre-
lation as low SES in childhood increases the risk of infectious
diseases including chronic persistent infection with microbialte number of seropositivities to infectious agents, by TOAST-subgroups.
Crude ORa 95% CI SVD % Crude ORa 95% CI
2.11 0.80e5.58 3 2.11 0.73 0.21e2.55
0.73 0.48e1.11 70 49.30 0.75 0.52e1.08
1 0.65e1.54 69 48.59 0.87 0.60e1.27
0.82 0.50e1.33 104 73.24 1.10 0.71e1.69
1.29 0.81e2.04 38 26.76 1.05 0.68e1.60
1.04 0.65e1.66 32 22.54 0.72 0.46e1.11
0.82 0.38e1.80 13 9.15 0.99 0.52e1.89
0.85 0.52e1.38 54 38.03 1.53 1.04e2.25
1.30 0.84e2.01 49 34.51 1.18 0.79e1.74
1 54 38.03 1
0.94 0.56e1.59 54 38.03 0.75 0.49e1.15
1.58 0.87e2.86 27 19.01 0.93 0.54e1.58
0.56 0.12e2.55 5 3.52 0.95 0.34e2.66
1 38 26.76 1
0.86 0.50e1.46 47 33.10 1.09 0.67e1.75
0.66 0.36e1.19 39 27.46 1.07 0.65e1.76
1.22 0.60e2.46 16 11.27 1.04 0.53e2.04
1 34 23.94 1
0.97 0.55e1.70 43 30.28 0.96 0.58e1.59
0.73 0.40e1.35 41 28.87 1.01 0.61e1.69
0.95 0.47e1.90 22 15.49 1 0.54e1.86
Fig. 2. Socioeconomic risk score in childhood by combined IgA/IgG seropositivity.
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tween aggregate burden of infections and SES in childhood in cases,
and to aweaker degree in adolescence. In controls, such association
was less pronounced but signiﬁcant in childhood and not existent
in adolescence. These ﬁndings are in line with previous results.
However, addition of serological data only slightly attenuated the
effect of childhood socioeconomic status on stroke. Thus, the effect
of presently examined infections on the association between
childhood SES and IS is low.
Interestingly, advanced tooth loss (8e14 remaining teeth) and
avoidance of dental health care service were strongly and inde-
pendently associated with FEIS. Inclusion of the number of teeth
and the frequency of dentist visits reduced the strength of the as-
sociation between low SES in adulthood and stroke, and rendered it
nonsigniﬁcant. This indicates that behavioral and other factors that
are reﬂected by dental care or the sequelae of dental negligence
contribute to the link between SES and stroke, a ﬁnding that has not
been reported so far to the best of our knowledge. Of note, peri-
odontitis, a chronic infectious disease that is inﬂuenced by several
behavioral (e.g. smoking) and socioeconomic factors, is among the
most common contributors to the loss of teeth.
Our study has several limitations including the low number of
microbial agents assessed, the low number of subjects in etiologic
stroke subgroups a low response rate in controls and the fact that
diagnosis of prior MI (>90 days) was not analyzed separately. In
addition, the individual reason for missing teeth was unknown.Strengths of our study include the ample information on SES in
different life periods and on other stroke risk factors.
In conclusion, we could not ﬁnd that infectious burden as
assessed with ﬁve microbial agents independently contributes to
stroke risk in a consistent way. Low SES in childhood is associated
with stroke risk and with a higher number of antimicrobial sero-
positivities. However, this elevated infectious burden does not
contribute to our understanding of the link between childhood
conditions and stroke. Advanced tooth loss due to dental negli-
gence appears to be part of a lifestyle that contributes to the as-
sociation between disadvantageous adulthood SES and FEIS.Conﬂict of interest
The authors declared they do not have anything to disclose
regarding conﬂict of interest with respect to this manuscript.Financial support
This work was supported by the German Research Foundation
(DFG), [BE 2056/5-1, GR 1102/5-1, GR 1687/2-1], the Academy of
Finland (grant number 1266053), the Finnish Dental Association
Apollonia and the Yrj€o Jahnsson foundation.
F. Palm et al. / Atherosclerosis 254 (2016) 117e123 123Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.atherosclerosis.2016.10.008.
References
[1] V.L. Feigin, G.A. Roth, M. Naghavi, P. Parmar, R. Krishnamurthi, S. Chugh, et al.,
Global burden of stroke and risk factors in 188 countries, during 1990-2013: a
systematic analysis for the Global Burden of Disease Study 2013, Lancet
Neurol. 15 (2016) 913e924.
[2] F. Palm, M. Dos Santos, C. Urbanek, M. Greulich, K. Zimmer, A. Safer, et al.,
Stroke seasonality associations with subtype, etiology and laboratory results
in the Ludwigshafen Stroke Study (LuSSt), Eur. J. Epidemiol. 28 (2013)
373e381.
[3] Y. Liao, K.J. Greenlund, J.B. Croft, N.L. Keenan, W.H. Giles, Factors explaining
excess stroke prevalence in the US Stroke Belt, Stroke 40 (2009) 3336e3341.
[4] A.J. Grau, L. Marquardt, C. Lichy, The effect of infections and vaccinations on
stroke risk, Expert Rev. Neurother. 6 (2006) 175e183.
[5] A.J. Grau, C. Urbanek, F. Palm, Common infections and the risk of stroke, Nat.
Rev. Neurol. 6 (2010) 681e694.
[6] B. Galobardes, G.D. Smith, J.W. Lynch, Systematic review of the inﬂuence of
childhood socioeconomic circumstances on risk for cardiovascular disease in
adulthood, Ann. Epidemiol. 16 (2006) 91e104.
[7] A. Flex, E. Gaetani, P. Papaleo, G. Straface, A.S. Proia, G. Pecorini, et al.,
Proinﬂammatory genetic proﬁles in subjects with history of ischemic stroke,
Stroke 35 (2004) 2270e2275.
[8] A.J. Grau, H. Becher, C.M. Ziegler, C. Lichy, F. Buggle, C. Kaiser, et al., Peri-
odontal disease as a risk factor for ischemic stroke, Stroke 35 (2014) 496e501.
[9] P.J. Pussinen, G. Alfthan, H. Rissanen, A. Reunanen, S. Asikainen, P. Knekt,
Antibodies to periodontal pathogens and stroke risk, Stroke 35 (2004)
2020e2023.
[10] P.J. Pussinen, G. Alfthan, P. Jousilahti, S. Paju, J. Tuomilehto, Systemic exposure
to Porphyromonas gingivalis predicts incident stroke, Atherosclerosis 193
(2007) 222e228.
[11] M.R. Preusch, A.J. Grau, F. Buggle, C. Lichy, J. Bartel, C. Black, et al., Association
between cerebral ischemia and cytotoxin-associated gene-A-bearing strains
of Helicobacter pylori, Stroke 35 (2004) 1800e1804.
[12] J. Ngeh, C. Goodbourn, Chlamydia pneumoniae, Mycoplasma pneumoniae,
and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS,
L-PEPS): a case-control study on the infectious burden of atypical respiratory
pathogens in elderly patients with acute cerebrovascular disease, Stroke 36
(2005) 259e265.
[13] P. Apfalter, Chlamydia pneumoniae, stroke, and serological associations:
anything learned from the atherosclerosis-cardiovascular literature or do we
have to start over again? Stroke 37 (2006) 756e758.
[14] M.S. Elkind, P. Ramakrishnan, Y.P. Moon, B. Boden-Albala, K.M. Liu,
S.L. Spitalnik, et al., Infectious burden and risk of stroke: the northern Man-
hattan study, Arch. Neurol. 67 (2010) 33e38.
[15] J. Addo, L. Ayerbe, K.M. Mohan, S. Crichton, A. Sheldenkar, R. Chen, et al.,
Socioeconomic status and stroke: an updated review, Stroke 43 (2012)
1186e1191.
[16] H. Becher, F. Palm, A. Aigner, A. Safer, C. Urbanek, F. Buggle, et al., Socioeco-
nomic conditions in childhood, adolescence, and adulthood and the risk of
ischemic stroke, Stroke 47 (2016) 173e179.
[17] L.J. Murray, E.E. McCrum, A.E. Evans, K.B. Bamford, Epidemiology of Heli-
cobacter pylori infection among 4742 randomly selected subjects from
Northern Ireland, Int. J. Epidemiol. 26 (1997) 880e887.
[18] F. Palm, C. Urbanek, S. Rose, F. Buggle, B. Bode, M.G. Hennerici, et al., Stroke
incidence and survival in Ludwigshafen am Rhein, Germany: the Ludwig-
shafen stroke study (LuSSt), Stroke 41 (2010) 1865e1870.
[19] P.J. Pussinen, T. Vilkuna-Rautiainen, G. Alfthan, K. Mattila, S. Asikainen, Mul-
tiserotype enzyme-linked immunosorbent assay as a diagnostic aid forperiodontitis in large-scale studies, J. Clin. Microbiol. 40 (2002) 512e518.
[20] F. Palm, C. Urbanek, J. Wolf, F. Buggle, T. Kleemann, M.G. Hennerici, et al.,
Etiology, risk factors and sex differences in ischemic stroke in the Ludwig-
shafen Stroke Study, a population-based stroke registry, Cerebrovasc. Dis. 33
(2012) 69e75.
[21] R RCT, A Language and Environment for Statistical Computing, R Foundation
for Statistical Computing, Vienna, Austria, 2013.
[22] T T. A Package for Survival Analysis in S. R Package Version 2.37-7, 2014.
http://CRANR-projectorg/package¼survival.
[23] E V Clinfun: Clinical Trial Design and Data Analysis Functions. R Package
Version 1.0.11. http://CRANR-projectorg/package¼clinfun.
[24] A. Paganini-Hill, E. Lozano, G. Fischberg, M. Perez Barreto, K. Rajamani,
S.F. Ameriso, et al., Infection and risk of ischemic stroke: differences among
stroke subtypes, Stroke 34 (2003) 452e457.
[25] P.J. Lindsberg, A.J. Grau, Inﬂammation and infections as risk factors for
ischemic stroke, Stroke 34 (2003) 2518e2532.
[26] B. Schottker, M.A. Adamu, M.N. Weck, H. Muller, H. Brenner, Helicobacter
pylori infection, chronic atrophic gastritis and major cardiovascular events: a
population-based cohort study, Atherosclerosis 220 (2012) 569e574.
[27] N. Hosomi, S. Aoki, K. Matsuo, K. Deguchi, H. Masugata, K. Murao, et al., As-
sociation of serum anti-periodontal pathogen antibody with ischemic stroke,
Cerebrovasc. Dis. 34 (2012) 385e392.
[28] A.W. Haider, P.W. Wilson, M.G. Larson, J.C. Evans, E.L. Michelson, P.A. Wolf, et
al., The association of seropositivity to Helicobacter pylori, Chlamydia pneu-
moniae, and cytomegalovirus with risk of cardiovascular disease: a prospec-
tive study, J. Am. Coll. Cardiol. 40 (2002) 1408e1413.
[29] S. Sealy-Jefferson, B.W. Gillespie, A.E. Aiello, M.N. Haan, L.B. Morgenstern,
L.D. Lisabeth, Antibody levels to persistent pathogens and incident stroke in
Mexican Americans, PLoS One 8 (2013) e65959.
[30] A.D. Haffajee, M.A. Cugini, A. Tanner, R.P. Pollack, C. Smith, R.L. Kent, et al.,
Subgingival microbiota in healthy, well-maintained elder and periodontitis
subjects, J. Clin. Periodontol. 25 (1998) 346e353.
[31] A. Ikeda, H. Iso, S. Sasazuki, M. Inoue, S. Tsugane, The combination of Heli-
cobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to
the risk of myocardial infarction in middle-aged Japanese: the Japan Public
Health Center-based study, Atherosclerosis 230 (2013) 67e72.
[32] M. Desvarieux, R.T. Demmer, D.R. Jacobs, P.N. Papapanou, R.L. Sacco,
T. Rundek, Changes in clinical and microbiological periodontal proﬁles relate
to progression of carotid intima-media thickness: the Oral Infections and
Vascular Disease Epidemiology study, J. Am. Heart Assoc. 2 (2013) e000254.
[33] E. Kononen, S. Paju, P.J. Pussinen, M. Hyvonen, P. Di Tella, L. Suominen-Taipale,
et al., Population-based study of salivary carriage of periodontal pathogens in
adults, J. Clin. Microbiol. 45 (2007) 2446e2451.
[34] A. Johansson, I. Johansson, M. Eriksson, A.M. Ahren, G. Hallmans, B. Stegmayr,
Systemic antibodies to the leukotoxin of the oral pathogen Actinobacillus
actinomycetemcomitans correlate negatively with stroke in women, Cere-
brovasc. Dis. 20 (2005) 226e232.
[35] P.J. Pussinen, E. Kononen, S. Paju, K. Hyvarinen, U.K. Gursoy, S. Huumonen, et
al., Periodontal pathogen carriage, rather than periodontitis, determines the
serum antibody levels, J. Clin. Periodontol. 38 (2011) 405e411.
[36] T.G. Glaros, S. Chang, E.A. Gilliam, U. Maitra, H. Deng, L. Li, Causes and con-
sequences of low grade endotoxemia and inﬂammatory diseases, Front. Biosci.
Sch. Ed. 5 (2013) 754e765.
[37] C.H. Chiang, C.C. Huang, W.L. Chan, Y.C. Chen, T.J. Chen, S.J. Lin, et al., Asso-
ciation between Mycoplasma pneumonia and increased risk of ischemic
stroke: a nationwide study, Stroke 42 (2011) 2940e2943.
[38] J. Ngeh, S. Gupta, C. Goodbourn, G. McElligott, Mycoplasma pneumoniae in
elderly patients with stroke. a case-control study on the seroprevalence of M.
pneumoniae in elderly patients with acute cerebrovascular disease e the M-
PEPS Study, Cerebrovasc. Dis. 17 (2004) 314e319.
[39] S. Kiechl, G. Egger, M. Mayr, C.J. Wiedermann, E. Bonora, F. Oberhollenzer, et
al., Chronic infections and the risk of carotid atherosclerosis: prospective re-
sults from a large population study, Circulation 103 (2001) 1064e1070.
